| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.1 | 0.02 |